Canada Approves Celltrion’s Remsima SC Biosimilar

Company Plans to Expand From Initial RA Indication To Also Cover IBD

 
• By Akriti Seth
  
Canada Flag
Celltrion receives Health Canada approval for its subcutaneous version of Remsima • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products